Wellington scientists have patented a ground-breaking vaccine for asthma.
Trial results published today show the vaccine works in mice, preventing inflammation of the lungs and airways.
The vaccine is a novel way of dealing with allergies which, if successful in humans, could be expanded to other allergies and diseases.
The research, published in Nature Chemical Biology, was a collaboration between the Malaghan Institute and Victoria University’s Ferrier Research Institute.
Malaghan Institute vaccine therapy programme leader Ian Hermans said the successful mice trial results were exciting.
However, it would take at least five years of further research before the vaccine could be proven in humans.
Malaghan immune cell biology programme leader Franca Ronchese said the vaccine worked by stimulating the immune system to produce killer T-cells, which hunted down the dendritic cells that took up allergens and triggered inflammation.
“It’s like taking out the generals of the enemy’s army in order to overpower it.”
New Zealand has one of the highest asthma rates in the world, with up to one in five Kiwis affected.
A vaccine giving long-term protection would transform the lives of the 500,000 New Zealanders dependent on asthma inhalers, Ronchese said. “What we hope is that it’s not like having to take drugs for your asthma, where you have to take them all the time.
“In our mouse patients we have evidence that it can work over a long time. We can give them the allergen again and again and it still works.”
Hermans said the vaccine was also unique in that the critical components were linked to “clever chemistry”. “It’s a much more potent way of stimulating the immune response than to just grab the two components, mix them up and inject them.”
The Latest on: Asthma vaccine
[google_news title=”” keyword=”Asthma vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Asthma vaccine
- Savvy Senior: Recommended vaccines for Medicare recipientson April 26, 2024 at 5:30 am
Here’s a rundown of which vaccines are recommended by the Centers for Disease Control and Prevention and how Medicare covers them.
- Census change will lead to more data on health of Middle Eastern, North African people in USon April 26, 2024 at 5:06 am
Before the successful, healthy birth of her son, recalls Germine Awad — an Egyptian American who is a psychologist at the University of Michigan — clinicians told her that her hormone levels were too ...
- Parents, listen up! Local kids could be helping get rid of RSV and another major health concernon April 25, 2024 at 2:40 pm
CLEVELAND — Young children in our area could be the key to a new vaccine for a potentially dangerous illness…RSV. Back in November, we told you about a study that hoped to find a longer-lasting ...
- Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earningson April 25, 2024 at 6:47 am
Sanofi reports Q1 operating income at 2.8 billion euros, down 14.7%. Beat consensus EPS at $0.97. Sales reach $11.36 billion, led by Dupixent's 24.9% surge. Vaccine sales up 5.6%. Expecting Dupixent ...
- Sanofi reports 1Q revenue increase, as sales of vaccines, Dupixent riseon April 25, 2024 at 3:53 am
Sanofi, a pharmaceutical company with Monroe County operations, reported a 2.4% gain in first-quarter revenue on Thursday, as sales of vaccines and the anti-inflammatory drug Dupixent increased.
- Future parents more likely to get RSV vaccine when pregnant if aware RSV can be a serious illness in infants: Studyon April 24, 2024 at 9:00 pm
Likelihood to receive the RSV vaccine during pregnancy was also higher among parents ... associated with long-term wheezing and higher risk of future hospitalization for asthma symptoms compared with ...
- RSV vaccine boosts Monroe County's Sanofi Pasteuron April 24, 2024 at 5:00 pm
Vaccine sales rose 5.6% compared to the year-ago quarter ... and the projection for 2024 is about 13 billion euros. Dupixent treats eczema and asthma, and is being studied as a treatment for COPD ...
- Immunity from COVID Booster is Superior to Primary Serieson April 23, 2024 at 6:10 am
COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster. Unfortunately... | Microbiology ...
- Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuringon April 19, 2024 at 1:04 pm
French healthcare and pharma company Sanofi will terminate an undisclosed number of positions in its U.S. vaccines commercial unit in an effort to streamline the strategic sales structure.
- Hesitant about getting a flu vaccine this winter? Here is what you need to knowon April 16, 2024 at 9:22 am
The flu is one of the most unpleasant common illnesses, with symptoms such as aches, pains, chills, fever, and cough. Additional symptoms such as runny nose, vomiting, diarrhoea, fatigue, and sore ...
via Bing News